Live Longer CategoriesLive Longer
Trending Topic: NICE
Skin cancer pill doubles survival
A pill taken twice a day has been found to nearly double the length of time that patients with advanced skin cancer survive. A trial in Vancouver of 132 people with metastatic melanoma found that, on ...Health boss tells patients to sue
Professor Sir Michael Rawlins, chair of the National Institute of Health and Clinical Excellence, has said that economic pressure on trusts meant that “completely illegal” decisions were b...DNA testing to open up expensive cancer drugs
According to Professor Matthew Seymour, a British scientist, DNA testing could open the door for cancer drugs deemed too expensive for the NHS to be prescribed for certain patients. Professor Seymour ...Doctors unaware of stress guidelines
A survey has found that half of UK doctors are unaware of official guidelines on how to diagnose mental health trauma. The news could lead to fears that thousands of combat veterans aren’t being...DIY blood pressure checks for NHS patients
Fears of misdiagnosis in the doctor’s surgery have led to patients being given home monitoring devices. A phenomenon known as ‘white-coat hypertension’ means that about a quarter of ...The first skin cancer drug since the 1970′s to extend life
Ipilimumab, the first new treatment for advanced skin cancer since the 70′s, is an injectant that teaches the body’s immune system to fight back against melanoma. The substance must be inj...Leukaemia drug available after price slash
A pharmaceutical giant cut the cost of a potentially life-saving drug, making it more available to leukaemia sufferers. The NHS rationing body, NICE (National Institute for Health and Clinical Excelle...Menopausal women are denied cancer drugs
Two drugs known to treat advanced breast cancer in post-menopausal women have been rejected for use by the NHS when combined with hormone therapy. Issuing its final guidance, NICE (National Institute ...New clot-busting heart attack drug given the go-ahead
A new clot-busting drug called ticagrelor has been approved by the NHS funding watchdog. The drug cuts the risk of dying from a second heart attack by 20%, and could benefits thousands of patients. Th...The new test that could prevent chemotherapy
A new gene test is being hailed by specialists in the UK as a breakthrough in breast cancer diagnosis. Oncotype DX can help women and their doctors decide if they need chemotherapy after breast cancer...
